Challenges in early-stage cutaneous T-cell lymphoma – diagnosis and management

This webcast was broadcasted live on December 14th. Did you miss the live webcast? The webcast will soon be available on demand.
Leave your details here so we can inform you as soon as the on demand webcast is accreted and available.

Cutaneous T-cell lymphomas (CTCL) are malignant neoplasms that belong to the class of non-Hodgkin lymphomas (NHL). CTCL are a histologically and prognostically heterogeneous group. The most common CTCL variants include mycosis fungoides (MF) and Sézary syndrome (SS). The extremely variable clinical presentation, lack of a single specific diagnostic test, diverse histopathologic and immunohistochemical examination findings, and specific staging make diagnosis particularly difficult in these rare diseases. Key therapeutic goals include induction of remission, symptoms relief, and improvement of quality of life.

Join us in this interactive expert meeting where our experts will focus on the challenges in early-stage cutaneous T-cell lymphoma.


  • Basics of CTCL
  • Diagnosis
  • Management and monitoring of early-stage MF


Prof. dr. Maarten Vermeer
dermatologist, LUMC Leiden, The Netherlands
Prof. dr. Rudolf Stadler
dermatologist, Johannes Wesling Klinikum, Minden, Germany



This webinar is primarily intended for dermatologists, hematologists, oncologists and pathologists.


Accreditation has been requested.

Free webinar

Participation in this webinar is free of charge.


If you have any questions, please send an email to


This is a non promotional event sponsored by:

In the context of GDPR, Springer complies with the laws and regulations as laid down by this law. For this webinar it applies that it concerns a collaboration between Springer and Kyowa Kirin and that they each determine their own purpose and means in the processing of personal data. Springer and Kyowa Kirin are therefore separately responsible for processing. The privacy conditions that apply can be found here: Springer Healthcare & Kyowa Kirin.



To continue reading, please log in

Log in with your BSL Account

Log in

Forgot your password?

No BSL Account yet? Please register


More information on BSL Accounts.